Recruiting Pulmonary Hypertension Studies in Ann Arbor
About Pulmonary Hypertension Clinical Trials in Ann Arbor
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 29 pulmonary hypertension clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 10,962 participants. Research is being sponsored by Population Health Research Institute, University of Pennsylvania, University of Milano Bicocca and 21 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Ann Arbor — FAQ
Are there pulmonary hypertension clinical trials in Ann Arbor?
Yes, there are 29 pulmonary hypertension clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 29 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated October 12, 2026 from ClinicalTrials.gov